The Department of Health of Human Services Aug. 21 issued a request for information seeking feedback on immunization categories within the Aug. 10 executive order announcing changes to the federal government’s recommended childhood vaccine schedule.
COVID-19: Vaccines and Therapeutics
For the 2025-2026 school year, exemptions from one or more vaccines among U.S. kindergartners was at 4.2%, increasing from 3.6% for the previous school year, according to data released Aug. 17 by the Centers for Disease Control and Prevention.
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices used to treat COVID-19, saying circumstances justifying the authorizations no longer exist.
Funded Partnerships fosters transformative health care collaborations supported by AHA and its 501c3, the Health Research & Educational Trust (HRET).
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a population at high risk of severe illness from the disease.
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing emergency department or urgent care visits for children ages 9 months to 4 years.
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-19 vaccine.
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that puts them at high risk for severe outcomes from the disease. The vaccine also is approved for adults 65 years of age or older.
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention would no longer recommend the COVID-19 vaccine for healthy children and pregnant women.
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England Journal of Medicine.